









Markets
/
Stocks
/
nasdaq-hrow
/

Harrow Inc

HROW

View Detailed Chart

34.930USD

+3.560+11.35%

Close 07/11, 16:00（ET）Quotes delayed by 15 min

1.25BMarket Cap

LossP/E TTM



Harrow Inc

34.930

+3.560+11.35%

Overview Company Financials

Financials

Intraday

30m

Today

+11.35%

5 Days

+10.02%

1 Month

+10.50%

6 Months

-4.75%

Year to Date

+4.11%

1 Year

+47.14%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

BUY

Current Rating

58.743

Target Price

87.26%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

170

Total

Median

Average

Company name

Ratings

Analysts

Harrow Inc

HROW

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(0)

Buy(10)

Indicators

Sell(1)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.171

Buy

RSI(14)

70.237

Buy

STOCH(KDJ)(9,3,3)

68.869

Buy

ATR(14)

1.467

High Vlolatility

CCI(14)

341.478

Overbought

Williams %R

11.224

Overbought

TRIX(12,20)

0.379

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

32.066

Buy

MA10

31.484

Buy

MA20

31.302

Buy

MA50

28.751

Buy

MA100

27.198

Buy

MA200

34.078

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the North American market. The Company offers a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Ticker SymbolHROW

CompanyHarrow Inc

CEOMr. John P. Saharek

Websitehttps://www.harrow.com/